Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Patrizia Vici et al.|Journal of Clinical Oncology|2005Cited by 96
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Journal of Clinical Oncology|2003Cited by 76
Addition o f E ither L onidamine o r G ranulocyte Colony-Stimulati ng F actor D oes N ot I mprove S urvival i n E arly Breast C ancer P atients T reated W ith H igh-Dose E pirubicin and C yclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Unknown|2003Cited by 0